TY  - GEN
AU  - Dulucq,Stephanie
AU  - Etienne,Gabriel
AU  - Morisset,Stephane
AU  - Klein,Emilie
AU  - Chollet,Claudine
AU  - Robbesyn,Fanny
AU  - Turcq,Beatrice
AU  - Tigaud,Isabelle
AU  - Hayette,Sandrine
AU  - Nicolini,Franck E
AU  - Mahon,François-Xavier
TI  - Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line
SN  - 1432-0584
PY  - 2019///0425
KW  - Adult
KW  - Aged
KW  - Disease-Free Survival
KW  - Female
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Imatinib Mesylate
KW  - administration & dosage
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - RNA, Messenger
KW  - RNA, Neoplasm
KW  - Survival Rate
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s00277-019-03633-x
ER  -